Iranian Heart Association Iranian Heart Journal 18 2 2017 06 01 Comparison of the Prevalence of Postprocedural Myocardial Infarction Between Diabetic and Nondiabetic Patients in a Non-Emergent Setting 36 42 83118 EN Farshad Shakerian Cardiovascular Intervention Research Center, RajaieCardiovascular,Medical,and Research Center; Iran University of Medical Sciences,Tehran, I.R.Iran. Momohammad ALi Sadr-Ameli Sadr-Ameli Cardiovascular Intervention Research Center, RajaieCardiovascular,Medical,and Research Center; Iran University of Medical Sciences,Tehran, I.R.Iran. Maryam Alsadat Mousavi RajaieCardiovascular,Medical, and Research Center,Iran University of Medical Sciences, Tehran, I.R.Iran. Hamid-Reza Sanati Cardiovascular Intervention Research Center, RajaieCardiovascular,Medical,and Research Center; Iran University of Medical Sciences,Tehran, I.R.Iran. Ata Firouzi Cardiovascular Intervention Research Center, RajaieCardiovascular,Medical,and Research Center; Iran University of Medical Sciences,Tehran, I.R.Iran. Ali Zahedmehr Cardiovascular Intervention Research Center, RajaieCardiovascular,Medical,and Research Center; Iran University of Medical Sciences,Tehran, I.R.Iran. Reza Kiani Cardiovascular Intervention Research Center, RajaieCardiovascular,Medical,and Research Center; Iran University of Medical Sciences,Tehran, I.R.Iran. Mahdyie Doaee Community Medicine Specialist, Iran University of Medical Sciences, Tehran, I.R.Iran Akbar Nikpajouh RajaieCardiovascular,Medical, and Research Center,Iran University of Medical Sciences, Tehran, I.R.Iran Journal Article 2019 02 27 Background: Diabetes is the cause of 25% of all the cases of coronary artery disease and myocardial infarction (MI). One of the best interventions for coronary artery occlusion treatment is percutaneous coronary intervention (PCI). In PCI, myocardial area size, lesion morphology, cardiac function, renal failure, and other comorbidities are very important. Evaluation of the periprocedural MI prevalence is significant for comparing diabetic and nondiabetic patients. Methods: This cross-sectional study was done in Rajaie Cardiovascular, Medical, and Research Center by convenience sampling in 2009. PCI was performed on 605 patients, comprising 171 diabetic and 434 nondiabetic patients. Our information form included the type of contrast, arterial access, diabetic type, blood glucose control, lab tests, and number of coronary artery lesions. The incidence of postprocedural MI was evaluated by the measurement of CK-MB. The data were then entered into SPSS before they were described and analyzed. The χ2 test and the t-test were employed for data evaluation. Results: The incidence of post procedural MI was 2.9% in the diabetics and 2.5% in the nondiabetics. Moreover, 71.7 % of the patients were diabetic and 28.3% were nondiabetic. The blood glucose level was controlled in 12.6% of the study population, while it was not controlled in 87.4%. The P value for the comparison of periprocedural MI between the diabetic and nondiabetic patients was 0.788. All of the 5 diabetic patients with periprocedural MI belonged to the uncontrolled blood glucose group. The highest frequency of MI was in the patients with 3-vessel PCI (P=0.027). Conclusions: No significant statistical difference was observed regarding postprocedural MI between the diabetic and nondiabetic patients. Preprocedural MI was more frequent in the patients with 3-vessel PCI. PCI is a safe procedure with a low incidence rate of postprocedural MI. (Iranian Heart Journal 2017; 18(2):36-42) https://journal.iha.org.ir/article_83118_16335c85f7a27e54f2321e12666c896e.pdf